The global immunohistochemistry market was valued at $2,388.5 million in 2021 and is projected to reach $4,530.56 million by 2031, registering a CAGR of 6.5% from 2022 to 2031. Immunohistochemistry is a valuable technique that is used for the identification and visualization of tissue antigens in biological research and clinical diagnostics. In addition, Immunohistochemistry (IHC) is a diagnostic technique that is conducted in a laboratory. It involves performing special tests on your biopsy tissue sample to help diagnose the disease more precisely.
The key factors that drive the growth of the market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease and a rise in healthcare expenditure boosts the market growth. However, a dearth of skilled professionals restricts the market growth in the forecast period. Moreover, rise in technological advancements in IHC, increase in a number of product approvals and availability of reimbursements for IHC tests offer lucrative opportunities to the market player operating in the immunohistochemistry market.
The global Immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research applications, and forensics. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research, the application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and thermo Fischer Scientific, Inc
The key factors that drive the growth of the market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease and a rise in healthcare expenditure boosts the market growth. However, a dearth of skilled professionals restricts the market growth in the forecast period. Moreover, rise in technological advancements in IHC, increase in a number of product approvals and availability of reimbursements for IHC tests offer lucrative opportunities to the market player operating in the immunohistochemistry market.
The global Immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research applications, and forensics. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research, the application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and thermo Fischer Scientific, Inc
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global immunohistochemistry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Antibody
- Type
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Type
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Diluents
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Other
- Kits
- Type
- IHC Kits for Animal Tissue
- IHC Kits for Human Tissue
- Equipment
- Type
- Slide staining Systems
- Tissue Processing Systems
- Slide Scanners
- Others
By Application
- Diagnosis
- Type
- Infectious diseases
- Neurological diseases
- Nephrological diseases
- Autoimmune diseases
- Cancer
- Others
- Research Applications
- Type
- Drug Testing
- Others
- Forensic
By End User
- Hospital and Diagnostic Labs
- Research Institutes and Academic Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Italy
- Spain
- Rest of Europe
- Germany
- France
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies Inc
- Abcam Plc
- F hoffman La Roche
- Merck Kgaa
- Biorad Laboratories
- Thermofischer Scientific Inc
- Cell Signaling Technology, Inc
- Bio SB
- Takara Bio, Inc
- PHC Holdings Corporation
- Miltenyi Biotec
- CANDOR Bioscience GmbH
- Sakura Finetek Japan Co., Ltd
- Eagle Biosciences, Inc.
- Biocare Medical, LLC
- Elabscience, Inc.
- Biogenex Laboratories
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT
CHAPTER 5: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION
CHAPTER 6: IMMUNOHISTOCHEMISTRY MARKET, BY END USER
CHAPTER 7: IMMUNOHISTOCHEMISTRY MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Immunohistochemistry Market," the Immunohistochemistry Market size was valued at $2.4 billion in 2021 and is estimated to reach $4.5 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031.Immunohistochemistry is a technique that is used to diagnose numerous chronic illnesses like cancer and cardiovascular and infectious diseases. It is a highly sensitive method that allows the localization of antigens within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen.
The key Immunohistochemistry Market trends are the rise in the prevalence of chronic disease, the rise in the geriatric population and increase in healthcare expenditure across the world drivesImmunohistochemistry Market growth. According to a report published by the World Health Organization, in 2021, non-communicable diseases (NCDs) killed around 41 million people each year, which was 71% of all deaths globally. However, lack of skilled professionals restricts the market growth in the forecast period.
The global Immunohistochemistry Industry is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research application, and forensic. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.
On the basis of product, the immunohistochemistry market has been segmented into antibodies, reagents, equipment, and kits. In 2021, the antibodies segment accounted for the largest share of the market. The dominance of this segment can be attributed to an increase in use of primary and secondary antibodies in immunohistochemistry tests for the diagnosis of disease.
On the basis of application, the diagnosis segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to an increase in the prevalence of various chronic diseases such as cancer, diabetes, and others across the world.
Depending on the end user the immunohistochemistry market is segmented into hospitals & diagnostic laboratories, academic & research institutes, and other end users. In 2021, the hospitals & diagnostic laboratories segment accounted for the largest share of 48.0%. The large share of this segment was attributed due to the increase in the number of patient visits to hospitals for diagnosis of various chronic diseases.
North America accounted for a majority of the immunohistochemistry market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rise in a number of chronic disease cases, the presence of key players, and advancements in healthcare in the region. For instance, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes which are leading causes of death and disability and they are also a leading driver of the healthcare costs in this region.
Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in medical tourism, implementation of new ICT guidelines in Japan, investments, and reforms to modernize China’s healthcare infrastructure, rapid growth in the healthcare industry in India to support the market growth in this region.
Key players that operate in the immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and Thermofisher Scientific, Inc.
Key Findings of the Study
- By product, the antibodies segment was the highest contributor to the market in 2021.
- By application, the diagnosis segment was the highest contributor to the market in 2021.
- By end user, the hospital & diagnostics laboratories segment is projected to grow at a significant CAGR of 7.3% from 2022 to 2031.
- By region, North America garnered largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 7.5% during the review period.
Companies Mentioned
- Agilent Technologies Inc
- Abcam plc
- F Hoffman La Roche
- Merck Kgaa
- Biorad Laboratories
- Thermofischer Scientific Inc
- Cell Signaling Technology, Inc
- Bio Sb
- Takara Bio, Inc
- Phc Holdings Corporation
- Miltenyi Biotec
- Candor Bioscience GmbH
- Sakura Finetek Japan Co. Ltd
- Eagle Biosciences, Inc.
- Biocare Medical, LLC
- Elabscience, Inc.
- Biogenex Laboratories
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 385 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2388.5 million |
| Forecasted Market Value ( USD | $ 4530.56 million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
